VUS Diagnostics is a company that understand the functional impact of gene variants in genetic disease including cancers.
VUS Diagnostics has raised $322K in total funding. The most recent round was Pre-Seed. The last funding was announced in November 2023.
VUS Diagnostics's investors include Innovatiefonds Noord-Holland.
VUS Diagnostics is headquartered in Amsterdam, The Netherlands.
VUS Diagnostics is a company that understand the functional impact of gene variants in genetic disease including cancers.
VUS Diagnostics is at the Pre-Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"VUS Diagnostics — Funding & Investors." VCBacked, November 6, 2023, https://www.vcbacked.co/company/vus-diagnostics. Accessed August 17, 2026.
VCBacked. (2023). VUS Diagnostics — Funding & Investors. Retrieved August 17, 2026, from https://www.vcbacked.co/company/vus-diagnostics
{{cite web |title=VUS Diagnostics — Funding & Investors |url=https://www.vcbacked.co/company/vus-diagnostics |website=VCBacked |access-date=August 17, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated